Baird Medical Investment (BDMD) Stock Price, News & Analysis

Company Overview

Baird Medical Investment Holdings Limited is a medical device company focused on minimally invasive tumor treatment technologies. Through its operating subsidiaries, the company develops, manufactures and markets microwave ablation systems designed to destroy targeted tissue using heat generated by microwave energy.

Its product portfolio includes microwave ablation generators, disposable ablation needles and related accessories. The systems are used primarily in the treatment of thyroid nodules and other solid tumors, with applications that may include liver, breast and other soft-tissue conditions. Baird Medical also provides related technical support, physician training and procedure assistance.

The company’s business originated in China, where it has built relationships with hospitals and medical institutions and conducts much of its commercial activity. Baird Medical has also stated that it is pursuing international opportunities for its microwave ablation technology. Baird Medical Investment Holdings Limited is incorporated as a holding company, with its operating activities conducted through subsidiaries.

Key Stats

• Today's Range: $0.08 to $0.11
• 50-Day Range: $0.09 to $1.17
• 52-Week Range: $0.07 to $3.70
• Volume: 32.59 million shs
• Average Volume: 29.69 million shs
• Market Capitalization: $3.71 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Baird Medical Investment Stock Analysis - MarketRank™

Baird Medical Investment scored higher than 33% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Baird Medical Investment has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Baird Medical Investment has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 75.00%

Earnings Growth

Earnings for Baird Medical Investment are expected to grow by 75.00% in the coming year, from $0.08 to $0.14 per share.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.25% of the float of Baird Medical Investment has been sold short.

Short Interest Ratio / Days to Cover

Baird Medical Investment has a short interest ratio ("days to cover") of 0.36, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Baird Medical Investment has recently decreased by 15.63%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Baird Medical Investment does not currently pay a dividend.

Dividend Growth

Baird Medical Investment does not have a long track record of dividend growth.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.15

News Sentiment

Baird Medical Investment has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Baird Medical Investment this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for BDMD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

1 people have added Baird Medical Investment to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Baird Medical Investment insiders have not sold or bought any company stock.

Percentage Held by Insiders

78.90% of the stock of Baird Medical Investment is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

19.78% of the stock of Baird Medical Investment is held by institutions.

Company Calendar

• Today: 11/08/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:BDMD
• Previous Symbol: NASDAQ:BDMD
• CIK: 1982444
• Web: www.bairdmed.com
• Phone: 86 159 1316 5120
• Fax: N/A
• Employees: 146
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $22.54 million
• Price / Sales: 0.16
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 42,210,000
• Free Float: 8,906,000
• Market Cap: $3.71 million
• Optionable: N/A
• Beta: -0.98